Heroin to Bupe: Opioid Use Disorders and Treatments
As a result of participating in this lecture, learners should have a working knowledge of the following topics, essential to competency in addiction medicine and identify areas where more study may be needed.
- Epidemiology of opioid addiction, focusing on prevalence and any emerging patterns, demographics/socio-cultural factors of addicted populations, heroin vs po opioid addiction epidemiology
- Cost to society
- Etiology: biological, genetic, psychosocial factors
- Medical Assessment and Diagnosis; DSM 5 criteria for opioid use disorders, physical signs of intoxication and withdrawal, sequelae of chronic use, medical emergencies (od, drug-drug interactions)
- Management: Pharmacotherapy. Include management of withdrawal and detox as well as maintenance treatments; methadone, suboxone, non-opioid detox regimens, maintenance therapy with agonists, maintenance therapy with antagonists, complementary and alternative health approaches
- Naloxone: how to use
Judith Martin, MD
Dr. Martin is an addiction medicine physician who has worked with opioid-addicted patients and their families for over twenty years. She has provided training about methadone and buprenorphine treatment of addiction to physicians and clinic staff from many states. She is past president of the California Society of Addiction Medicine, and on the board of directors for the American Society of Addiction Medicine. She is Medical Director of Substance Use Services for the Department of Public Health in San Francisco, where she works on integrated care issues in mental health, primary care, and addiction medicine.
No relevant financial/ non-financial relationships with any propriertary interests.
- 1.00 California Board of Behavioral Sciences
- 1.00 NCCPA
- 1.00 AAPA
- 1.00 AMA Category 1
- 1.00 CAADAC